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Generation of purified neural precursors from embryonic stem
cells by lineage selection
Meng Li*, Larysa Pevny†, Robin Lovell-Badge† and Austin Smith*
Mouse embryonic stem (ES) cells are non-transformed
cell lines derived directly from the pluripotent founder
tissue in the mouse embryo, the epiblast [1–3].
Aggregation of ES cells triggers the generation of a
diverse array of cell types, including neuronal cells
[4–7]. This capacity for multilineage differentiation is
retained during genetic manipulation and clonal
expansion [8]. In principle, therefore, ES cells provide
an attractive system for the molecular and genetic
dissection of developmental pathways in vitro. They are
also a potential source of cells for transplantation
studies. These prospects have been frustrated,
however, by the disorganised and heterogeneous
nature of development in culture. We have therefore
developed a strategy for genetic selection of lineage-
restricted precursors from differentiating populations.
Here, we report that application of such lineage
selection enables efficient purification of
neuroepithelial progenitor cells that subsequently
differentiate efficiently into neuronal networks in the
absence of other cell types.
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Results and discussion
For induction of neural differentiation, ES cells are aggre-
gated in suspension to form embryoid bodies, exposed to
retinoic acid, and then allowed to reattach to a substratum
[4,6]. Neuronal-like cells can be detected in the out-
growths, accompanied by a variety of other cell types. We
introduced two variations to the protocol that enhanced
the final representation of neuronal cells. First, the embry-
oid bodies were dissociated before plating. This results in
a homogeneous dispersion and terminates inductive and
selective effects within the embryoid bodies. Second, cells
were plated in a defined culture medium — DMEM/F12
plus N2 supplement — on substrata coated with 
poly-D-lysine and laminin, which support attachment and
outgrowth of neuronal cells. 
These procedures had an additive effect on the proportion
of neural cells in the cultures. When combined, up to 50%
of viable cells extended neuritic processes and became
immunoreactive for the neuronal markers neurofilament
light and heavy chains, microtubule-associated proteins,
MAP2 and tau, or β-tubulin III. A smaller proportion of
cells, up to 20%, expressed the astrocyte marker glial fib-
rillary acidic protein (GFAP). Comparable results were
obtained with three independent ES cell lines. Non-
neural cell types remained in these cultures, however, in
particular, flat epithelioid cells. If the basal medium was
supplemented with serum or with basic fibroblast growth
factor (bFGF or FGF-2), these non-neural cells expanded
rapidly, and progressively became the predominant cell
types (data not shown).
At the time of plating, neither neuronal nor astrocyte
markers were detectable. Cultures at this stage were
therefore examined for expression of neural-precursor
markers. Almost all cells expressed the intermediate fila-
ment protein, nestin, which is expressed in neuroepithe-
lium but also in somitic mesoderm [9,10]. The
SRY-related transcription factors Sox1 and Sox2 are more
specific markers. Sox1 is confined to the neuroepithelium
of the neural plate and dividing neural progenitors in the
early mouse embryo [11] whereas Sox2 is found in an
overlapping pattern that also encompasses floor plate and
early neural crest cells [12]. Immunostaining of freshly
plated cells with antibodies against Sox1 and Sox2
revealed that 40–50% of the cells were positive for each
marker (Figure 1; Table 1). This approximates to the final
proportion of differentiated neural cells, consistent with
the notion that cells expressing Sox1 and Sox2 correspond
to neural-restricted progenitors. 
To attempt to isolate the neural progenitor pool, we
used ES cells in which the bifunctional selection
marker/reporter gene βgeo has been integrated into the
Sox2 gene by homologous recombination (A. Avilion, S.
Nicolis, L.P., L. Perez, N. Vivian, R.L.-B., unpub-
lished). When induced to differentiate as described
above, approximately 50% of these cells stained for 
β-galactosidase activity (Figure 1; Table 1), consistent
with the proportion of cells that express Sox2 protein.
Therefore, we reasoned that application of G418 to the
differentiating cultures should eliminate Sox2-negative
non-neural cells. G418 (200 µg/ml) was added after
retinoic-acid induction, either during embryoid body
culture or upon plating. In both conditions appreciable
cell killing was evident. Crucially, however, large
numbers of cells survived that exhibited the small, ovoid
morphology typical of neuroepithelial cells. Over 90% of
these cells showed prominent β-galactosidase staining
(Figure 1; Table 1). Expression of Sox1 and Sox2 
proteins was confirmed by immunostaining (Figure 1; 
Table 1). Consistent with a neuroepithelial identity, the
cells also expressed nestin (Table 1). 
In order to gauge the diversity of neural differentiation
that could be achieved with ES cells in the absence of
embryonic axial organisation, we have begun to examine
expression of key determinants — Pax genes and neuro-
genic basic helix-loop-helix (bHLH) transcription factors.
The paired-box transcription factors Pax3 and Pax6 are
found in dividing neural precursors throughout the length
of the embryonic neural tube. Pax3 is initially expressed
in the neural plate and subsequently becomes confined to
the dorsal half of the neural tube [13]. Pax6 is expressed
predominantly in the ventral region of the neural tube
[14,15]. Widespread expression of both Pax genes was
found in Sox2-selected cells analysed on the day of plating
(Table 2). This suggests that ES-cell-derived neural pre-
cursors can acquire both dorsal and ventral identities. It is
thought that the presence of the bHLH factors Mash1
and Math4A defines distinct subpopulations of neural
progenitors, because the distribution of these two tran-
scription factors is mutually exclusive in most central
nervous system (CNS) regions [16]. Expression of both
genes was detected in sub-populations of Sox2-selected
cultures (Table 2). This mosaic expression of determina-
tion genes within the Sox2-selected cultures appears
reflective of the sub-specification of progenitors within
the neural tube [15]. Requirements for specification and
differentiation of individual progenitor types could there-
fore be investigated in this system, both by addition of
extracellular factors and by genetic manipulation of the
ES cells prior to differentiation. 
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Figure 1
Enrichment for Sox2-positive cells by G418 selection. ES cells with a
targeted insertion of βgeo into the Sox2 gene were induced to form
embryoid bodies, and treated with retinoic acid. Cultures were (a,c,e)
unselected or (b,d,f) exposed to G418 (200 µg/ml) for the final 48 h of
aggregate culture. Cells were analysed 3 h after plating. (a,b) Sox2-
linked β-galactosidase expression in (a) an unselected culture and (b)
a G418-selected culture. (c,d) Immunostaining with anti-Sox1 antibody
in (c) an unselected culture and (d) a G418-selected culture. (e,f)
Counterstaining with 4,6-diamidino-2-phenylindole (DAPI) of the
cultures shown in panels c and d, respectively. Scale bar below (f)
represents 100 µm for (a,b) and 66.7 µm for (c–f). 
Table 2
Expression of neural markers in Sox2-selected cultures.
Marker Number of Percentage of
cells scored positive cells
Pax6 764 46.2 ± 9.8
Pax3 319 35.5 ± 8.8
Mash1 361 24.2 ± 7.6
Math4A 679 13.8 ± 6.3
Delta1 72 30.6 ± 4.7
Islet1 901 2.8 ± 0.9
Cells incubated in the presence of G418 for the final 48 h of embryoid
body culture were analysed 3–4 h after plating, except for Islet1
detection which was performed after 24 h. Data for Pax3, Pax6 and
Mash1 are averaged from two independent experiments, and for the
other markers are from duplicate wells from a single experiment. (For
images of primary data, see Supplementary material published with this
paper on the internet.)
Table 1
Expression of neuroepithelial markers following G418
selection.
Marker Percentage of positive cells
–G418 +G418
β-galactosidase 43.8 ± 9.4 (1035) 91.0 ± 2.6 (536)
Sox2 48.4 ± 1.1 (537) 95.5 ± 1.1 (510)
Sox1 46.6 ± 5.6 (239) 88.7 ± 5.1 (490)
Nestin 90.0 ± 6.5 (212) 94.0 ± 3.2 (298)
The numbers within parentheses indicate the number of cells scored.
Two early markers of neuronal differentiation were also
examined. The Notch ligand Delta1 is expressed by com-
mitted cells immediately prior to neuronal differentiation
[17]. Delta1 transcripts were detectable in around 30% of
cells on the day of plating, indicating that a significant
minority of the cells are already committed to terminal dif-
ferentiation. Expression of the LIM homeodomain
protein Islet1, an early marker of differentiation of motor
neurons and ventral interneurons [18], was examined in
Sox2-selected cultures both by in situ hybridisation and by
immunostaining. A small number of positive cells (2–3%)
were reproducibly detected 24–48 hours after plating
(Table 2). This indicates that specific subtypes of neu-
ronal differentiation can be initiated in these cultures.
The co-expression of Sox and Pax genes is associated with
proliferative neuroectoderm in vivo. In order to determine
whether the Sox2-selected population had proliferative
capacity, bFGF [19,20] was added to plated cultures.
This resulted in a major stimulation of cell division.
Figure 2 shows typical X-gal-stained cultures 24 and 96
hours after addition of bFGF. The expanded cells pre-
dominantly retained undifferentiated morphology and
showed strong X-gal staining indicative of Sox2 expres-
sion. Such cultures could be amplified and serially pas-
saged for at least three weeks, which is significantly
longer than the proliferative phase of neurogenesis in the
mouse embryo. 
In the absence of mitogen, Sox2-selected precursor cells
began to extend neuritic processes within 48 hours and by
96 hours formed a network of neuron-like cells
(Figure 3b). The pan-neuronal markers neurofilament
light chain (data not shown), microtubule-associated pro-
teins, MAP2 and tau, and β-tubulin III were detectable
from 48 hours onwards, coincident with down-regulation
of Sox2 expression (Figure 3). By 96 hours, over 90% of
cells expressed neuronal markers, including neurofilament
heavy chain and synapsin I. Cells of non-neuronal mor-
phology were rarely apparent, with the exception of the
occasional GFAP-positive astrocyte. Astrocyte numbers
increased if serum or FGF was added to the cultures. Mat-
uration of the neuronal cells, evidenced by production of
gamma-aminobutyric acid (GABA) and glutamate neuro-
transmitters (see Supplementary material), and further
elongation of neurites with dendritic sprouting (Figure 3b)
was achieved on transfer to Neurobasal medium supple-
mented with B27 and horse serum. 
This ability to generate pure populations of neurons,
combined with the relative ease of genetic modification
of ES cells, offers a new route for manipulation and char-
acterisation of neuronal development and cell biology.
The finding that major cellular components of embryoid
bodies can be ablated without apparently perturbing
development of the surviving cells also suggests that this
strategy could be adapted to isolate stem or precursor
cells for other lineages. An important attribute is that
unlike immunopurification techniques this approach is
not limited to cell-surface antigens but could be applied
to any differentially expressed gene regardless of the
nature of its product. The most obvious potential is for
exploiting the growing number of genes which have been
identified that encode transcription factors with lineage-
restricted expression. Selected populations could readily
be refined by introducing independent markers into more
than one gene. 
The advantage of targeting progenitors as opposed to 
differentiated cells [21] is the potential for subsequent
amplification and directed differentiation both in vitro [5]
and in vivo. ES cell derivatives can colonise host tissue
and differentiate after transplantation into adult 
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Figure 2
Sox2-expressing cells proliferate in vitro in response to bFGF.
Embryoid bodies were dissociated, and cells were plated in
DMEM/F12 supplemented with N2 in the presence of 10 ng/ml bFGF
and 200 µg/ml G418. (a) Overnight culture; (b) 4 day culture. Cell
numbers increased around 10-fold over this culture period and
maintained Sox2 expression as shown by X-gal staining. The scale bar
is 200 µm and applies to both panels. 
recipients. Grafts of whole embryoid body cultures,
however, also give rise to teratomas and other benign or
malignant growths [22,23]. Furthermore, heterologous
cells may interfere with trophic signals and guidance cues
from host tissue to transplanted cells. Prior lineage purifi-
cation should eliminate these problems and enable the
multipotentiality ES cells to be harnessed effectively for
application in cellular transplantation.
Supplementary material
Examples of staining for various markers, and further methodological
details are published with this paper on the internet.
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Figure 3
ES-cell-derived neurons differentiated following Sox2 selection.
Embryoid bodies — either (a) unselected or (b–f) selected by exposure
to G418 for 48 h — were dissociated and plated in N2 medium for
(c,d) 48 h or (e,f) 96 h, or (a,b) 72 h followed by a further 72 h in
Neurobasal medium plus B27 supplement and 2% horse serum. (a)
Representative unselected culture showing neuronal and non-neuronal
cell types. (b) Typical field of neurons differentiated after Sox2
selection. (c,d) Double immunolabelling showing (c) down-regulation
of Sox2 in newly differentiating cells expressing (d) the neuronal
marker β-tubulin III. (e,f) Double immunolabelling for neuronal markers
(e) synapsin I and (f) MAP2. The scale bar below (f) represents (a)
150 µm or (b) 75 µm or (c–f) 66.7 µm.
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Materials and methods
ES cell culture
ES cell lines used in this study were: E14TG2a [S1], CGR8 [S2] and
CCE-Sox2, a derivative of CCE in which one copy of the Sox2 gene
has been disrupted by homologous recombination (A. Avilion, S.
Nicolis, L.P., L. Perez, N. Vivian, R.L.-B., unpublished). All ES cell lines
were maintained on gelatin-coated tissue culture plastic in Glasgow
modified Eagle’s medium (GMEM) supplemented with 10–4 M 2-mer-
captoethanol, 10% fetal calf serum (FCS) and 100 U/ml LIF [S3]. 
Induction of differentiation
The basic protocol is based on that described [S4]. ES cells were
lightly trypsinized into small clumps and allowed to aggregate in sus-
pension culture in the absence of LIF. After 4 d culture, all trans-retinoic
acid (RA) was added at a concentration of 10–6 M. After a further four
days, aggregates were dissociated by incubation with trypsin and tritu-
ration. Cells were seeded at 3 × 105 cells/well into 4-well dishes (Nunc)
coated with poly-D-lysine and laminin. Dissociated cells were initially
cultured in serum-free DMEM/F12 supplemented with N2. For longer
term culture, they were transferred after three days to Neurobasal
medium plus B27 supplement (Gibco-BRL) and 2% horse serum. 
Substrate preparation
Tissue culture plates were precoated with poly-D-lysine (PDL,
30–70 kDa, Sigma) for 20 min at a concentration of 10 µg/ml in PBS.
Excess PDL was withdrawn and the plates were rinsed with PBS three
times before coating with laminin (Sigma) at a concentration of
2–10 µg/ml in PBS overnight at 4°C. 
Immunocytochemistry 
Staining for Sox1 and Sox2 was carried out on cultures fixed in
MEMFA (4% formaldehyde, 100 mM MOPS pH 7.4, 20 mM EGTA,
1 mM MgSO4) for 1 h. To stain cells with antibodies against GABA and
glutamate, cells were fixed with 1% glutaraldehyde in PBS. For detec-
tion of other intracellular antigens, cultures were fixed in 4%
paraformaldehyde in PBS for 15 min. Fixed cells were rinsed with PBS,
incubated with blocking buffer (PBS, 1 mg/ml BSA, 0.1% Triton X-
100, and 1% goat serum) for 30 min followed by incubation with
primary antibodies in blocking buffer overnight at 4°C. Cells were then
rinsed with PBS and incubated with a species-specific secondary anti-
body in blocking buffer for 1 h. Cultures were washed with three
changes of PBS, mounted with Vectashield mounting media (Vector)
and examined under a fluorescent microscope, or were developed for
enzyme-linked staining using the Vectastain ABC kit. Double labelling
experiments were performed by simultaneously incubating cells in
appropriate combinations of primary antibodies, followed by incubation
Supplementary material
Figure S1
Expression of region-specific neural precursor markers in Sox2-
selected cultures. Sox2-expressing cells were selected with G418 for
2 day in embryoid body cultures; cells were dissociated and allowed to
attach to culture dishes for 3 h before fixation. The expression of
transcripts encoding (a) Pax3, (b) Delta1, (c) Mash1 and (d) Math4A
were detected by in situ hybridisation with specific anti-sense
riboprobes. The presence of Pax6-expressing cells was detected by
(e) staining the culture with an anti-Pax6 antibody, and (f) double
labelling with DAPI to visualise nuclei of all cells. Scale bar, 50 µm.
Figure S2
Expression of neurotransmitters by neurons differentiated after Sox2
selection. Sox2-positive cells — selected by exposure to G418 for 48 h
during embryoid body culture — were plated and grown in the absence
of G418 in N2 medium for 72 h, followed by a further 72 h in
Neurobasal medium plus B27 supplement and 2% horse serum. 
(a) Immunostaining for GABA. (b) Phase contrast image of field in (a).
(c) Immunostaining for glutamate. (d) Phase contrast image of field in
(c). Scale bar, 66.7 µm.
with non-cross-reactive secondary antibodies. In some experiments,
cultures were counter stained with propidium iodide or DAPI at con-
centrations of 1 ng/ml and 5 µg/ml, respectively.
The following dilutions were used for primary and secondary antibod-
ies: rabbit anti-Sox1 and anti-Sox2 (1:500), rabbit anti-GABA (1:2000,
Sigma), rabbit anti-glutamate (1:4000, Sigma), mouse anti-β-tubulin 3
(1:200, Sigma); mouse anti-NF68 (1:400, Sigma); rabbit anti-MAPs,
which reacts with MAP2 and Tau (1:400, Sigma); mouse anti-GFAP
(1:400, Sigma), mouse anti-synapsin-I (1:50, Chemicon), mouse anti-
nestin (1:50, DSHB), mouse anti-Pax6 (1:10, gift of Dr D. Engelkamp),
mouse anti-Islet1 (1:2, DSHB), Cy3-conjugated goat anti-mouse IgG
(1/50, Jackson ImmunoResearch), FITC-conjugated goat anti-mouse
IgG (1:100, Sigma), FITC-conjugated goat anti-rabbit Ig (1:100,
Sigma), TRITC-conjugated goat anti-rabbit Ig (1:50, Sigma). 
In situ hybridisation of cultured cells
The protocol is based on that of [S5] adapted for cultured cells. Briefly,
cultures were fixed in 4% paraformaldehyde and permeabilised at
–20°C in 100% methanol. The cells were then rehydrated through a
series of methanol and finally put into PBS with 0.1% Tween-20. Pre-
hybridisation was performed for 1–4 h in hybridisation buffer (50%
ultrapure formamide, 5 × SSC pH 4.5, 50 mg/ml heparin, 100 µg/ml
herring sperm DNA and tRNA, 0.1% Tween-20). Digoxigenin (DIG)-
labelled probes were added at 1 µg/ml and specimens incubated
overnight at 70°C. Washes the following day were three times for
30 min at 65°C in wash buffer (50% formamide, 2 × SSC, 0.1%
Tween-20), three 5 min washes in TBST (137 mM NaCl, 25 mM Tris-
HCl, pH 7.6, 3 mM KCl, 0.1% Tween-20) and 1 h block in 10%
serum/TBST. Cells were then incubated overnight at 4°C with alkaline-
phosphatase-coupled anti-DIG antibody (1:2000, Boehringer-
Mannheim). The following day cells were washed three times 1 h with
TBST and three times for 10 min with alkaline phosphatase buffer
(APB, 100 mM NaCl, 100 mM Tris pH 9.5, 50 mM MgCl2, 0.1%
Tween-20). The alkaline phosphatase staining reaction was allowed to
proceed for 3 h to overnight with 4.5 µl/ml NBT an 3.5 µl/ml BCIP in
APB (Boehringer). 
DIG-labelled RNA probes
The murine cDNAs used as templates for riboprobes were a 519 bp
Pax3 fragment, a 700 bp Delta1 clone, a 670 bp Mash1 fragment and a
1.5 kb Math4A fragment. DNAs were linearised and RNA synthesis was
directed using T7, T3 or SP6 RNA polymerase, including DIG-labelled
nucleotide mix as recommended by the suppliers (Boehringer). Prod-
ucts were analysed on a 0.8% agarose gel and approximately 1 µg/ml
DIG-labelled antisense RNA was used for hybridisation of cells.
Detection of β-galactosidase 
Cells were fixed in fix buffer (0.2% glutaraldehyde, 0.1 M phosphate
buffer pH 7.2, 2 mM MgCl2, 5 mM EGTA) for 10 min at 4°C and washed
three times with wash buffer (0.1 M phosphate buffer pH 7.2, 2 mM
MgCl2). The cells were then incubated at 37°C overnight with 1 mg/ml
5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-gal), 4 mM potassium feri-
cyanide, 4 mM potassium ferrocyanide in wash buffer [S6].
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